substance p has been researched along with Nasal Polyps in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cvetković, G; Gaćeša, D; Perić, A; Vojvodić, D | 1 |
| Ewert, R; Felix, SB; Gläser, S; Gustavus, B; Koch, B; Kunkel, G; Noga, O; Schäper, C | 1 |
| Aluffi, P; Beatrice, F; Bottomicca, F; Perlasco, L; Sartoris, A | 1 |
| Fang, SY; Ohyama, M; Shen, CL | 1 |
| Woodhead, CJ | 1 |
| Drake-Lee, A; Jones, V; Lewin, I; Nayyar, S; Stanworth, D; Wells, A | 1 |
| Baroody, FM; Corey, JP; Gungor, A; Naclerio, RM; White, SR | 1 |
2 review(s) available for substance p and Nasal Polyps
| Article | Year |
|---|---|
[Nasal polyps and substance P: a preliminary report].
Topics: Antibodies, Monoclonal; Humans; Nasal Polyps; Substance P | 1994 |
Neuropeptides in nasal mucosa.
Topics: Bradykinin; Calcitonin Gene-Related Peptide; Cytokines; Eicosanoids; Histamine H1 Antagonists; Humans; Nasal Mucosa; Nasal Polyps; Neurokinin A; Neuropeptide Y; Platelet Activating Factor; Receptors, Calcitonin Gene-Related Peptide; Rhinitis; Substance P; Vasoactive Intestinal Peptide | 1994 |
1 trial(s) available for substance p and Nasal Polyps
| Article | Year |
|---|---|
Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Aspirin-Induced; Cell Count; Cyclopropanes; Cysteine; Eosinophils; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Nasal Lavage Fluid; Nasal Polyps; Neurokinin A; Quinolines; Substance P; Sulfides; Treatment Outcome | 2011 |
4 other study(ies) available for substance p and Nasal Polyps
| Article | Year |
|---|---|
Inflammatory mediators in nasal secretions of patients with nasal polyposis with and without aspirin sensitivity.
Topics: Aspirin; Asthma, Aspirin-Induced; Cross-Sectional Studies; Humans; Inflammation Mediators; Nasal Polyps; Rhinitis; Sinusitis; Substance P; Tryptases | 2023 |
Presence of neuropeptides in human nasal polyps.
Topics: Calcitonin Gene-Related Peptide; Dopamine beta-Hydroxylase; Humans; Immunohistochemistry; Nasal Polyps; Neuropeptide Y; Neuropeptides; Substance P; Vasoactive Intestinal Peptide | 1994 |
Levels of substance P and IgE decapeptide in nasal polyp fluid and matching sera: a preliminary study.
Topics: Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin E; Nasal Polyps; Peptide Fragments; Substance P | 1996 |
Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps.
Topics: Adolescent; Adult; Calcitonin Gene-Related Peptide; Capsaicin; Female; Humans; Male; Middle Aged; Nasal Mucosa; Nasal Polyps; Neurokinin A; Neuropeptides; Nose Neoplasms; Prospective Studies; Reference Values; Respiratory Hypersensitivity; Substance P | 1999 |